Image
30.03.2022
DUKPC Digest Day 3: New findings on Flash and updates on type 2 and fa...
On day 3 of Diabetes UK's Professional Conference (DUKPC), we heard about:
findings from our clinic...
News & Views
From research findings showing a step forward for beta cell therapy without immunosuppression in type 1 diabetes, to a triple hormone drug that shows promise to treat type 2, here are some of the diabetes research developments announced in March 2026.
Read more
Showing 242 articles
Image
29.03.2022
DUKPC Digest Day 2: Immunotherapy research for type 1, screening and m...
On day 2 of the Diabetes UK Professional Conference (DUKPC) we heard about
exciting advances on th...
Image
28.03.2022
DUKPC Digest Day 1: Health inequalities, the pandemic and causes of ty...
We’ve just kicked off Diabetes UK's annual professional conference (DUKPC). It sees hundreds of healthcar...
Image
15.03.2022
£2.2 million NewDAWN project to help more people go in to remission
We’ve joined forces with the National Institute for Health Research (NIHR) to fund a new £2.2 million pro...
Image
25.02.2022
Shift-Diabetes: developing dietary support for shift-workers living wi...
The Shift-Diabetes research team at King’s College London is working to understand more about how night w...
Image
16.02.2022
Type 2 diabetes medications can also protect heart health
A new study funded by us has shown that certain diabetes medications can protect people living with type ...
Image
11.02.2022
International Day of Women and Girls in Science 2022: Meet Professor M...
We’re putting the spotlight on one of our many inspirational female researchers, who is working to improv...
Image
04.02.2022
Research priorities to improve care for older people with diabetes
Over a third of people living with diabetes in the UK are over the age of 65 but we don’t know enough abo...
Image
25.01.2022
Genes can protect some people from type 2 diabetes
A new study from our researchers has discovered that genes which control where our body fat is stored pla...
Image
18.01.2022
Our Future Health may hold the key to huge health discoveries
The UK’s largest-ever health research programme, called Our Future Health, aims to recruit up to five mil...
Image
11.01.2022
We invested over £6.6 million into new diabetes research in 2021
Your donations allowed us to get 30 innovative new diabetes research projects off the ground in 2021. Our...
Image
05.01.2022
Liver fat directly raises risk of type 2 diabetes
Our research has revealed that having higher levels of fat in the liver, and having a smaller pancreas, d...
Image
04.01.2022
Hormonal condition MACS linked to type 2 diabetes
Research we've funded has shown for the first time the scale and impact of MACS, a hormonal condition, th...
Image
17.12.2021
Our research brings us closer to new hypo treatments
Our researchers have found a way to activate a fuel gauge in the brain that could help in the development...
Image
18.11.2021
Low-calorie diets best to lose weight with type 2 diabetes
Researchers have examined all the evidence on which diets help people with type 2 diabetes to lose weight...
Image
18.11.2021
Dapagliflozin (Forxiga) is no longer to be used for type 1 diabetes
AstraZeneca has announced that the medication Dapagliflozin (Forxiga) will no longer be licensed for use ...
© The British Diabetic Association operating as Diabetes UK, a charity registered in England and Wales (no. 215199) and in Scotland (no. SC039136). A company limited by guarantee registered in England and Wales with (no.00339181) and registered office at Wells Lawrence House, 126 Back Church Lane London E1 1FH
